Add BrightSurf on Google Email

Blood test can help predict chronic lung disease in preterm babies

A new study from Murdoch Children's Research Institute has identified changes in certain blood proteins that can predict bronchopulmonary dysplasia (BPD) in preterm babies. By combining these protein changes with gestational age, birth weight, and sex, clinicians can make more accurate predictions of BPD risk within 72 hours of life.

SourceMurdoch Childrens Research Institute·JournalAmerican Journal of Respiratory Cell and Molecular Biology·TypeObservational study·DateAug 7, 2024

Genes or environment? A new model for understanding disease risk factors

A new model developed by Penn State researchers more accurately predicts the causal relationship between genetic and environmental factors in disease development. The study found that lifestyle and environmental factors play a larger role than previously believed, offering new opportunities to mitigate disease risk.

SourcePenn State·JournalNature Communications·TypeData/statistical analysis·DateJul 30, 2024

Immune response study explains why some people don't get COVID-19

Researchers used single-cell sequencing technology to study immune responses in healthy adult volunteers exposed to SARS-CoV-2. They discovered unique immune responses associated with resisting sustained viral infection and disease, including activation of specialized mucosal immune cells and a reduction in inflammatory white blood cells.

SourceWellcome Trust Sanger Institute·JournalNature·TypeExperimental study·DateJun 19, 2024

Heatwaves hit harder for people with disabilities: A Pusan National University study finds increased emergency visits

A Pusan National University study finds that heatwaves significantly impact public health among individuals with disabilities, increasing the risk of hospitalizations by 1.07 times. This results in a substantial economic burden, highlighting the need for well-informed public health policies to address these vulnerable groups.

SourcePusan National University·JournalThe Lancet Planetary Health·TypeObservational study·DateJun 11, 2024

CHEST Critical Care and CHEST Pulmonary receive indexation with Directory of Open Access Journals

The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed with the Directory of Open Access Journals (DOAJ), enhancing their open access content's accessibility and usage. The indexation is attributed to strong editorial boards led by Hayley Gershengorn and Matthew Miles.

SourceAmerican College of Chest Physicians·JournalCHEST Critical Care·DateMay 23, 2024

A study by UPF and BCNatal opens the door to designing therapies to improve lung development in growth-restricted fetuses

A study led by BCNatal and UPF found that growth-restricted fetuses have differences in lung vascular resistance, which can be normalized with extra oxygen. The research uses artificial intelligence techniques to analyze fetal blood flow and predicts the development of respiratory health problems later in life.

SourceUniversitat Pompeu Fabra - Barcelona·JournalScientific Reports·TypeExperimental study·DateMay 17, 2024

Study shows key role of physical activity and body mass in lung function growth in childhood

A new study published in Thorax reveals that increased physical activity and higher body mass index can help recover early-life lung function deficits, leading to normal values in adolescence. The study analyzed data from over 1,100 children and adolescents aged 4-18 years, identifying four trajectories of lung function growth.

SourceBarcelona Institute for Global Health (ISGlobal)·JournalThorax·TypeObservational study·DateApr 15, 2024

New mechanism discovered for the life-threatening arrhythmias in Andersen-Tawil syndrome

Researchers have discovered a direct link between the C122Y mutation in the Kir2.1 potassium channel and life-threatening arrhythmias in Andersen-Tawil syndrome, which affects fewer than 1 in a million people. The study highlights the importance of understanding the molecular mechanisms underlying cardiac arrhythmias.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalCirculation Research·TypeExperimental study·DateApr 10, 2024

Scientists close in on TB blood test which could detect millions of silent spreaders

Scientists have discovered six proteins that can accurately diagnose tuberculosis (TB). The breakthrough study paves the way for a simple blood test to detect the bacteria, which could prevent millions of cases annually. TB is the world's deadliest infectious disease, killing over one million people each year.

SourceUniversity of Southampton·JournalJournal of Clinical Investigation·TypeRandomized controlled/clinical trial·DateMar 22, 2024

Is active screening for tuberculosis among vulnerable populations cost-effective?

A systematic review by Gogichadze et al. suggests that active pulmonary TB screening programs targeting vulnerable populations in low-TB-incidence countries are cost-effective. The authors conclude that screening immigrants and other high-risk groups is a viable approach to detecting latent infections.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeSystematic review·DateMar 22, 2024

Infections from these bacteria are on the rise. New blood test cuts diagnosis time from months to hours

Tulane University researchers have developed a CRISPR-based platform for diagnosing nontuberculous mycobacteria (NTM) infections, allowing for accurate results in as little as two hours. The blood test can identify over 93% of patients with an NTM infection, enabling rapid treatment plans and reducing the risk of complications.

SourceTulane University·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 14, 2024

Who benefits from direct-to-consumer pharmaceutical advertising?

A UMass Amherst study found that government vaccine recommendations can benefit drugmakers like Pfizer, while also increasing vaccine uptake among seniors. However, the study suggests that direct-to-consumer advertising did not lead to a significant reduction in infection and mortality rates from pneumococcal disease.

SourceUniversity of Massachusetts Amherst·JournalJournal of Policy Analysis and Management·TypeObservational study·DateMar 12, 2024

Novel molecules from generative AI to phase II

Researchers used generative AI to design a lead molecule for treating fibrosis, a biological process associated with aging. The compound, INS018_055, demonstrated significant efficacy in preclinical studies and showed promising results in clinical trials, accelerating drug discovery and providing new therapeutic options.

SourceInSilico Medicine·JournalNature Biotechnology·DateMar 11, 2024

Large-scale study explores link between smoking and DNA changes across six racial and ethnic groups

A large-scale study has found a significant link between smoking and DNA methylation, with two new epigenetic markers identified that differ by race or ethnicity. The research could lead to better ways to predict smoking-related disease risk and improve early detection and treatment.

SourceKeck School of Medicine of USC·JournalAmerican Journal of Human Genetics·TypeObservational study·DateMar 1, 2024

Childhood tonsillectomy not linked to obesity in adulthood

A new study published in the American Journal of Respiratory and Critical Care Medicine found that childhood tonsillectomy is not associated with an increased risk of obesity in adulthood. The research followed 132 children who underwent tonsillectomy for obstructive sleep apnea and found no link to weight gain in adulthood.

SourceBen-Gurion University of the Negev·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeObservational study·DateFeb 29, 2024

Wildfire smoke disproportionately affects California's Indigenous communities, new research shows

Researchers found that Indigenous communities in California were exposed to 1.7 times more wildfire smoke than expected, with the average annual exposure being a critical factor in understanding long-term health effects. The study proposes new metrics to measure cumulative exposure and duration of smoke exposure.

SourceUniversity of California - Berkeley·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateFeb 29, 2024

Think smoking cannabis won’t damage your heart? Think again

A study by UC San Francisco researchers found that daily cannabis users had a 25% increased risk of heart attack and a 42% increased risk of stroke compared to non-users. The study also found significant cardiovascular risks associated with cannabis use, including coronary heart disease and the combination of heart attack and stroke.

SourceUniversity of California - San Francisco·JournalJournal of the American Heart Association·DateFeb 28, 2024

Engineering a coating for disease-free produce

Researchers at Texas A&M University have developed a coating that bolsters the safety of fresh produce and provides enhanced protection against bacteria and fungi. The coating combines wax with nano-encapsulated cinnamon-bark essential oil in protein carriers to enhance antibacterial properties.

SourceTexas A&M University·JournalCurrent Research in Food Science·DateFeb 20, 2024

Chinese Medical Journal Pulmonary and Critical Care Medicine study reports a novel prognostic biomarker for lung cancer

Researchers identify a promising prognostic biomarker for lung cancer using circulating tumor DNA-based minimal residual disease detection. The study found that this method can effectively guide treatment decisions and predict recurrence risk, potentially modifying the lung cancer treatment paradigm.

SourceCactus Communications·JournalChinese Medical Journal - Pulmonary and Critical Care Medicine·TypeLiterature review·DateFeb 14, 2024

Better diagnosis and treatment of cryptococcosis

The new guideline aims to improve diagnosis and treatment of cryptococcosis, a fatal fungal infection that affects mainly the lungs and brain. It provides practical guidance for medical staff to recognize and manage invasive fungal infections, with the goal of improving patient survival rates.

SourceUniversity of Cologne·JournalThe Lancet Infectious Diseases·TypeObservational study·DateFeb 13, 2024